Laureate Pharma has entered into a cGMP contract manufacturing agreement with Cytheris SA, a clinical stage biopharma focused on immune modulation. Laureate will manufacture Cytheris’ lead product candidate, Interleukin-7 (IL-7), a fully glycosylated recombinant human protein and critical growth factor for immune T-cell recovery, for use in ongoing international clinical trials currently being conducted for treatment of HIV, HCV and cancer. Terms and conditions of the agreement were not di...